Compare HCA Health Inc (HCA) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Prospect Capital Corporation — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Prospect Capital Corporation trades at $1.72 (market cap $974.22M). The key difference: HCA Health Inc is far larger — about 98.9× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.01%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Prospect Capital Corporation for 78 Days on average.
| HCA | PSEC | |
|---|---|---|
Market Cap | $96.35B | $974.22M |
Volume | 1,079,453 | 5,779,996 |
Sector | Health | Financials |
52-Week High | $545.13 | $3.05 |
52-Week Low | $361.32 | $1.82 |
Typical Hold Time | 76 Days | 78 Days |
Enterprise Value | $146.88B | $2.73B |
Dividend Yield | 0.7% | 23.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $451.09, up 2.71% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q4 2025 and Q1-Q2 2026 exceeding expectations, supported by robust revenue growth from $70.6B in 2024 to $75.6B in 2025. Valuation metrics remain attractive with P/E of 14.92 and P/S of 1.31, while technical indicators signal bullish momentum above key support levels.
The outlook remains positive with 63% analyst buy ratings and $461.12 consensus target, though legal investigations and high debt levels pose risks. Revenue growth and operational efficiency provide upside potential, but investors should monitor regulatory developments and debt management closely given the 80.9% debt-to-asset ratio in 2025.
PSEC trades at $1.72, down 6.52% today, amid bearish technical signals and mixed fundamentals. The stock shows consistent earnings beats but faces revenue volatility with negative 2025 results. Recent news highlights dividend distributions and portfolio management activity, while analysts remain cautious with 55% hold ratings. Technical indicators show oversold conditions with RSI below 10, but moving averages signal continued downward pressure.
PSEC presents a high-risk opportunity with an 18%+ yield and deep NAV discount, but faces significant headwinds from portfolio contraction and declining investment income. The dividend cut to $0.035 improves coverage, yet persistent NAV erosion and bearish analyst sentiment suggest limited near-term upside. Investors should weigh the attractive yield against fundamental deterioration and technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
